Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bussac

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Translational Lung Cancer Research|February 17, 2025
Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case reportJulie Lasvergnas, Isabelle Monnet, Jean-Bernard Auliac, et al.
Revue Des Maladies Respiratoires|September 21, 2016
[Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement]J Caliez, I Monnet, A Pujals, et al.
Revue Des Maladies Respiratoires|November 29, 2024
[Evaluation of local anesthesia with buffered Xylocaine in pleural procedures: The DOULAPLUX study]V Guiraud-Chaumeil, H Goussault, A Boudjemaa, et al.
Pathologie-Biologie|June 30, 2012
[Targeted agents in the treatment of lung cancer]L Staudacher, L Teixeira, E Kempf, et al.
Targeted Oncology|September 21, 2022
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French StudyAssya Akli, Nicolas Girard, Vincent Fallet, et al.
Translational Lung Cancer Research|October 21, 2024
Double immune checkpoint inhibitor therapy for unresectable pleural mesothelioma rarely induces hyperprogressive disease: a case reportGaspard Naulleau, Isabelle Monnet, Gaëlle Rousseau-Bussac, et al.
Journal of Cancer Research and Therapeutics|December 13, 2022
Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 studyNicolas Paleiron, Radj Gervais, Gaelle Rousseau-Bussac, et al.
Lung Cancer (Amsterdam, Netherlands)|March 9, 2025
Evaluation of teleguided high-intensity exercise rehabilitation at home before lung-cancer surgery (PREPACHIR Study)Florent Vinas, Hélène Goussault, Laurent Boyer, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2019
Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)Renaud Descourt, Maurice Perol, Gaëlle Rousseau-Bussac, et al.
British Journal of Anaesthesia|February 4, 2014
Nitrous oxide does not produce a clinically important sparing effect during closed-loop delivered propofol-remifentanil anaesthesia guided by the bispectral index: a randomized multicentre studyN Liu, M Le Guen, N Boichut, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Translational Lung Cancer Research|February 17, 2025
Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case reportJulie Lasvergnas, Isabelle Monnet, Jean-Bernard Auliac, et al.
Revue Des Maladies Respiratoires|September 21, 2016
[Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement]J Caliez, I Monnet, A Pujals, et al.
Revue Des Maladies Respiratoires|November 29, 2024
[Evaluation of local anesthesia with buffered Xylocaine in pleural procedures: The DOULAPLUX study]V Guiraud-Chaumeil, H Goussault, A Boudjemaa, et al.
Pathologie-Biologie|June 30, 2012
[Targeted agents in the treatment of lung cancer]L Staudacher, L Teixeira, E Kempf, et al.
Targeted Oncology|September 21, 2022
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French StudyAssya Akli, Nicolas Girard, Vincent Fallet, et al.
Translational Lung Cancer Research|October 21, 2024
Double immune checkpoint inhibitor therapy for unresectable pleural mesothelioma rarely induces hyperprogressive disease: a case reportGaspard Naulleau, Isabelle Monnet, Gaëlle Rousseau-Bussac, et al.
Journal of Cancer Research and Therapeutics|December 13, 2022
Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 studyNicolas Paleiron, Radj Gervais, Gaelle Rousseau-Bussac, et al.
Lung Cancer (Amsterdam, Netherlands)|March 9, 2025
Evaluation of teleguided high-intensity exercise rehabilitation at home before lung-cancer surgery (PREPACHIR Study)Florent Vinas, Hélène Goussault, Laurent Boyer, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2019
Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)Renaud Descourt, Maurice Perol, Gaëlle Rousseau-Bussac, et al.
British Journal of Anaesthesia|February 4, 2014
Nitrous oxide does not produce a clinically important sparing effect during closed-loop delivered propofol-remifentanil anaesthesia guided by the bispectral index: a randomized multicentre studyN Liu, M Le Guen, N Boichut, et al.
Pageof 5